Viewing negative mentions of positive regulation of IL2 (H. sapiens) in monocytes

Full-text article links are indicated by after the article reference.

Document Target Regulator Anatomy Sentence
Iho et al. (1985)IL 2monocytesFurthermore, 1,25(OH)2D3 suppressed interleukin 1 (IL 1) production of monocytes (Mo), and the agent-treated Mo were unable to promote IL 2 production of non-adherent cells (NAC).
Ulmer and Flad (1982)Il-2monocytesHowever, the production of Il-2 by high-density lymphocytes did not reach the Il-2 production by low-density T-lymphocytes even in the presence of high numbers of additional monocytes.
Malkovský et al. (1987)IL-2monocytesHere we provide evidence that human monocytes display a substantially increased cytotoxic activity as a direct and rapid response to human recombinant IL-2 but not to human recombinant glycosylated interferon-gamma (IFN-gamma) or lipopolysaccharide.
Barcova et al. (1998)IL-2monocytesgp41 envelope protein of human immunodeficiency virus induces interleukin (IL)-10 in monocytes, but not in B, T, or NK cells, leading to reduced IL-2 and interferon-gamma production.
Chatila et al. (1987)IL-2monocytesSuch preparations fail to respond to optimal concentrations of the lectin phytohemagglutin (PHA) or interleukin 2 (IL-2), indicating the functional depletion of monocytes (Mo.) and of activated T cells, respectively.
Dawood et al. (1989)IL-2monocytesThe removal of monocytes did not bring IL-2 levels to normal.
Klein-Franke and Anderer (1995)IL-2monocyteActivation of NK cell cytotoxicity and monocyte cytotoxicity by IL-12 were independent of exogenous IL-2 and IFN gamma.
Byrne et al. (1989)IL-2monocytesThe addition of IL-2 or monocytes to T0 cells stimulated with anti-CD2 antibodies did not enhance their expression of the IL-2 receptor or proliferation.
Zanussi et al. (1999)IL-2monocyteWhile HAART alone had negligible effects on cytokine production by PBMC, the combined use of HAART + IL-2 was unable to increase the endogenous production of IL-2, but caused an increase of IL-4, IL-13 and interferon-gamma (IFN-gamma) and a reduction of monocyte chemoattractant protein-1 (MCP-1) production.
Nielsen et al. (2005)interleukin-2monocyteRESULTS: Within the 3-Impact Powder group, no significant changes in concentrations of interleukin-6, interferon-gamma, monocyte chemoattractant protein-1, interleukin-2, interleukin-5 and interleukin-10, whereas a significant differences in concentration of interleukin-1beta and interleukin-4 were observed during therapy.
Frieboes et al. (1999)interleukin-2monocyteUnder PAN treatment, tumor necrosis factor (TNF)-alpha, soluble TNF receptors p55 and p75, and soluble interleukin-2 receptor levels were not increased and neither were monocyte and lymphocyte counts affected.